and biological data, to facilitate the understanding of brain tumors as well as several inherited neurological conditions (e.g., epilepsy and seizure disorders, Huntington’s disease, autism spectrum and neuromuscular ...
By SOPHiA GENETICS based in Boston, MASSACHUSETTS (USA).
QyScore® is a groundbreaking neuroimaging analysis platform for both clinical routine and clinical trial settings. One scan at a time, QyScore® has the potential to revolutionize the treatment of CNS disease and create the potential for earlier precision on the frontlines of CNS ...
By Qynapse based in Paris, FRANCE.
Technology that excavates biomarkers through an analysis of brainwaves in epilepsy or Alzheimer’s patients, predicts the likelihood of onset, or diagnoses the advance, based on the degree of change of brainwave biomarkers measured by a wearable EEG (AI-electroencephalogram) measuring instrument allowing. ...
By Theramx Inc. based in Seongnam-si, SOUTH KOREA.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you